Home › Stocks › DNTH › All Fund Holders
DNTH — DIANTHUS THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 38 · Reported value held: $2.43B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 8.20M | $799.33M | 0.04% | Add |
| BlackRock Inc history | Q2 2026 | 4.12M | $401.99M | 0.01% | Add |
| Wellington Management Group history | Q2 2026 | 3.23M | $314.85M | 0.06% | Add |
| Geode Capital Management history | Q2 2026 | 1.26M | $122.70M | 0.01% | Add |
| UBS Group AG history | Q2 2026 | 1.14M | $111.15M | 0.01% | Add |
| Citadel Advisors history | Q2 2026 | 1.03M | $100.01M | 0.01% | Reduce |
| Franklin Resources history | Q2 2026 | 968.98K | $94.46M | 0.02% | Hold |
| Vanguard Group history | Q4 2025 | 2.05M | $84.42M | 0.00% | Add |
| Farallon Capital Management history | Q1 2026 | 836.00K | $70.16M | 0.46% | New |
| Point72 Asset Management history | Q1 2026 | 643.60K | $54.01M | 0.07% | Reduce |
| Northern Trust Corp history | Q2 2026 | 411.79K | $40.14M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 382.16K | $37.25M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 365.96K | $35.67M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 256.83K | $25.04M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 256.39K | $24.99M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 162.00K | $15.79M | 0.02% | Reduce |
| Marshall Wace history | Q2 2026 | 128.74K | $12.55M | 0.01% | Reduce |
| Two Sigma Investments history | Q2 2026 | 107.45K | $10.47M | 0.01% | New |
| Morgan Stanley history | Q2 2026 | 106.38K | $10.37M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 91.84K | $8.95M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 85.60K | $8.34M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 69.76K | $6.80M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 62.83K | $6.12M | 0.01% | Reduce |
| Citigroup Inc history | Q2 2026 | 56.84K | $5.54M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 44.81K | $4.37M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 42.93K | $4.18M | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 39.47K | $3.85M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 31.78K | $3.21M | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 32.33K | $3.15M | 0.00% | Add |
| PSP Investments history | Q4 2025 | 48.48K | $2.00M | 0.01% | New |
| Prudential Financial history | Q2 2026 | 18.59K | $1.81M | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 16.50K | $1.38M | 0.00% | Add |
| Renaissance Technologies history | Q4 2025 | 32.10K | $1.32M | 0.00% | New |
| Polen Capital Management history | Q2 2026 | 9.33K | $909.78K | 0.01% | Add |
| Principal Global Investors history | Q2 2026 | 3.62K | $352.68K | 0.00% | New |
| AQR Capital Management history | Q2 2026 | 2.97K | $289.91K | 0.00% | Reduce |
| Amundi US history | Q2 2026 | 2.94K | $286.79K | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 2.51M | $245.16K | 0.03% | Add |